Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1

BACKGROUND: Adiposity and non-alcoholic fatty liver disease (NAFLD) are common characteristics of metabolic syndrome (MS). Understanding the underlying pathogenesis is crucial for the development of new remedies. Resveratrol controls obesity and glycemic disorders in patients with MS. OBJECTIVES: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamardl, Hanan Abdel Moneam A., Ibrahim, Noha A., Merzeban, Dina H., Elamir, Azza M., Golam, Rehab M., Elsayed, Asmaa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238348/
https://www.ncbi.nlm.nih.gov/pubmed/36991247
http://dx.doi.org/10.1007/s40199-023-00458-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238348/
https://www.ncbi.nlm.nih.gov/pubmed/36991247
http://dx.doi.org/10.1007/s40199-023-00458-y

Ejemplares similares